Jazz Pharmaceuticals
JAZZ
JAZZ
294 hedge funds and large institutions have $5.68B invested in Jazz Pharmaceuticals in 2016 Q4 according to their latest regulatory filings, with 47 funds opening new positions, 93 increasing their positions, 118 reducing their positions, and 72 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
294
Holders Change
-30
Holders Change %
-9.26%
% of All Funds
7.36%
Holding in Top 10
9
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.23%
New
47
Increased
93
Reduced
118
Closed
72
Calls
$41.4M
Puts
$65.5M
Net Calls
-$24.1M
Net Calls Change
+$14.8M
Top Buyers
| 1 |
TCP
Tourbillon Capital Partners
New York
|
+$83M |
| 2 |
Renaissance Technologies
New York
|
+$70.4M |
| 3 |
Adage Capital Partners
Boston,
Massachusetts
|
+$51.8M |
| 4 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
+$33.3M |
| 5 |
CC
Carlson Capital
Dallas,
Texas
|
+$32.5M |
Top Sellers
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
-$141M |
| 2 |
Viking Global Investors
Stamford,
Connecticut
|
-$89.6M |
| 3 |
Fidelity International
Hamilton,
Bermuda
|
-$62.6M |
| 4 |
Westfield Capital Management
Boston,
Massachusetts
|
-$41.3M |
| 5 |
Goldman Sachs
New York
|
-$36.2M |
